Sulphaphenazole and drug oxidation in man.
Open Access
- 1 October 1983
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 16 (4), 460-461
- https://doi.org/10.1111/j.1365-2125.1983.tb02199.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entitiesClinical Pharmacology & Therapeutics, 1982
- Application of the phenotyped panel approach to the detection of polymorphism of drug oxidation in man [proceedings].1979
- Pharmacogenetics of tolbutamide metabolism in humansDiabetes, 1979
- Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in ManPharmacology, 1979
- A direct radioimmunoassay for 6β-hydroxycortisol in human urineJournal of Steroid Biochemistry, 1978
- Mechanisms of inhibition of tolbutamide metabolism: Phenylbutazone, oxyphenbutazone, sulfaphenazoleClinical Pharmacology & Therapeutics, 1977
- Kinetics of drug-drug interactionsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Abbauhemmung von tolbutamid durch sulfaphenazol beim menschenEuropean Journal of Clinical Pharmacology, 1970
- SULPHAPHENAZOLE-INDUCED HYPOGLYCÆMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICSThe Lancet, 1963